Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients

doi:10.3748/wjg.v26.i27.3952

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 27

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9241)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

431

WORD

305

HTML

3974

Figures (1-1)

350

Tables (1-5)

352

Sum=5412

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

372

Download

932

Sum=1304

Publishing Process of This Article

Item

Count

Browse

789

Download

1736

Sum=2525

Jul 21, 2020 (publication date) through Jan 30, 2025

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jul 21, 2020; 26(27): 3952-3962
Published online Jul 21, 2020. doi: 10.3748/wjg.v26.i27.3952

Full Size Figure Download Figure

Figure 1 Receiver operating characteristic curves for the noninvasive models in all the study subjects. CPHBV: Ceruloplasmin hepatitis B virus; APRI: Aspartate aminotransferase-to-platelet ratio index; FIB-4: Fibrosis-4; GPR: Gamma-glutamyl transpeptidase-to-platelet ratio.

Citation: Kang NL, Zhang JM, Lin MX, Chen XD, Huang ZX, Zhu YY, Liu YR, Zeng DW. Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients. World J Gastroenterol 2020; 26(27): 3952-3962
URL: https://www.wjgnet.com/1007-9327/full/v26/i27/3952.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i27.3952